Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis

OBJECTIVES: Drugs for Neglected Diseases initiative (DNDi) has identified three chemical lead series, the nitroimidazoles, benzoxaboroles and aminopyrazoles, as innovative treatments for visceral leishmaniasis. The leads discovered using phenotypic screening, were optimised following disease- and co...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Int J Parasitol Drugs Drug Resist
Główni autorzy: Van Bocxlaer, Katrien, Caridha, Diana, Black, Chad, Vesely, Brian, Leed, Susan, Sciotti, Richard J., Wijnant, Gert-Jan, Yardley, Vanessa, Braillard, Stéphanie, Mowbray, Charles E., Ioset, Jean-Robert, Croft, Simon L.
Format: Artigo
Język:Inglês
Wydane: Elsevier 2019
Hasła przedmiotowe:
Includes articles from the special issue “Novel therapies for cutaneous leishmaniasis”, pp. 106 - 179
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6904836/
https://ncbi.nlm.nih.gov/pubmed/30922847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2019.02.002
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy